Pfizer submits request for vaccines for kids
At long last, a COVID-19 vaccine for children may be on its way.
Pfizer-BioNTech on Thursday submitted an application to the Food and Drug Administration (FDA) to get its vaccine approved for emergency use in children ages 5 to 11. The vaccine is already approved for people 12 and up.
According to its filing, vaccine dosages must be smaller than they are for older folks. But they seem to work well at preventing COVID-19 and have the same range of short-term side effects as they do in adults.
An advisory panel at the FDA is scheduled to consider the drug-makers’ application on October 26. Once approved, vaccine providers are ready to begin inoculating children.
The two companies are also in the process of testing their vaccine on children 2 to 5 years old and 6 months to 2 years old. The results of those trials are expected later this year.